Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders (U01 - Clinical Trial Optional)
The Ultra-Rare Gene-Based Therapy (URGenT) network supports Investigational New Drug (IND)-enabling studies and planning activities for First-in-Human (FIH) clinical testing of gene-based or transcript-directed therapeutics, such as oligonucleotides and viral-based gene therapies, for ultra-rare neurological or…
| From | National Institutes of Health |
|---|---|
| Who can apply | state governments, counties, cities and townships, special districts (water, fire, parks, etc.), school districts, public colleges and universities and 9 more types |
| Eligibility notes | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or… |
| How much | Amount not stated |
| Deadline | Fri, Oct 8, 2027 (350 days left) |
| Category | Health |
| Type | Cooperative agreement |
| Opportunity # | PAR-25-327 |
| Assistance listing | 93.853 |
| Posted | Wed, Dec 18, 2024 |